全球口服药物输送市场 – 行业趋势及 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球口服药物输送市场 – 行业趋势及 2029 年预测

  • Healthcare
  • Upcoming Report
  • Jan 2022
  • Global
  • 350 页面
  • 桌子數: 60
  • 图号: 220

Global Oral Drug Delivery Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2029
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram Major Markets Players
  • AbbVie
  • EnteraBio
  • Catalent
  • Novartis AG
  • Biocon

>全球口服药物输送市场,按类型(控释片、口腔崩解片、味觉调节)、应用(传染病、癌症、心血管疾病、糖尿病、呼吸系统疾病、中枢神经系统疾病、自身免疫性疾病、其他应用)、最终用户(医院、门诊手术中心、家庭护理环境、诊断中心、其他)、国家(美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区)划分的行业趋势和预测到 2029 年。

口服给药市场

市场分析与洞察 全球口服药物输送市场

预计口服药物输送市场在 2022 年至 2029 年的预测期内将以 7.60% 的速度增长。Data Bridge Market Research 关于口服药物输送市场的报告提供了有关预计在整个预测期内普遍存在的各种因素的分析和见解,同时提供了它们对市场增长的影响。全球医疗保健行业的崛起正在加速口服药物输送市场的增长。

药物输送系统是指用于以受控方式输送治疗剂的系统类型。药物通过各种途径输送,例如鼻腔、静脉或口服。这些药物也可以通过皮肤吸收。口服药物输送系统提供片剂和薄膜。

全球老年人口的增长是推动口服药物输送市场增长的主要因素之一。人们对自我管理和家庭护理设施的需求增加,以及对药物研发投资需求的激增加速了市场的增长。生物制剂市场的增长以及对生物仿制药和生物制剂的需求增加进一步影响了市场。此外,意识的增强、老龄化人口的激增、医疗行业的改善和慢性病的流行对口服药物输送市场产生了积极影响。此外,技术进步和新产品的推出为 2022 年至 2029 年预测期内的市场参与者提供了盈利机会。

另一方面,针刺伤风险预计将阻碍市场增长。预计在 2022-2029 年的预测期内,定价压力将对口服药物输送市场构成挑战。

This oral drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on oral drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Oral Drug Delivery Market Scope and Market Size

The oral drug delivery market is segmented on the basis of type, application and end- users. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

  • On the basis of type, the oral drug delivery market is segmented into controlled release, orodispersible tablets and taste making.
  • On the basis of application, the oral drug delivery market is segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications.
  • Oral drug delivery market is also segmented on the basis of end- users. The end- users segment is divided into hospitals, ambulatory surgical centers, home care settings, diagnostic centers and others.

Oral Drug Delivery Market Country Level Analysis

The oral drug delivery market is analyzed and market size insights and trends are provided by country, type, application and end- users as referenced above.      

The countries covered in the oral drug delivery market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

北美在口服药物输送市场占据主导地位,因为该地区癌症、呼吸道过敏和糖尿病等慢性病的发病率不断上升。由于该地区研发活动的增加,预计亚太地区 (APAC) 将在 2022 年至 2029 年的预测期内出现显着增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。消费量、生产地点和产量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

口服给药市场还为您提供每个国家/地区资本设备医疗保健支出增长、口服给药市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对口服给药市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。

竞争格局和口服药物输送市场份额分析

口服药物输送市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对口服药物输送市场的关注有关。

口服药物输送市场报告中的一些主要参与者包括 AbbVie Inc.、EnteraBio Ltd.、Catalent, Inc.、Novartis AG、Biocon.、Novo Nordisk A/S.、F. Hoffmann-La Roche Ltd、Bayer AG、3M、Evonik Industries、Skyepharma Production SAS、Chimerix.、SAMYANG BIOPHARMACEUTICAL CORPORATION、Oramed、Emisphere Technologies、Enteris BioPharma、AdhexPharma. 和 ARx, LLC. 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

North America dominates the oral drug delivery market because of the increase in prevalence of chronic diseases, such as cancer, respiratory allergies, and diabetes within the region.
The growth rate of the oral drug delivery market is 7.60%.
The rise in the geriatric population across the globe & the increase in demand for self-administration and home care facilities among people are the growth drivers of the oral drug delivery market.
Major companies in the oral drug delivery market are AbbVie Inc., EnteraBio Ltd., Catalent, Inc., Novartis AG, Biocon., Novo Nordisk A/S., F. Hoffmann-La Roche Ltd, Bayer AG, 3M, Evonik Industries, Skyepharma Production SAS, Chimerix., SAMYANG BIOPHARMACEUTICAL CORPORATION, Oramed, Emisphere Technologies, Enteris BioPharma, AdhexPharma., and ARx, LLC., among others.
Type, application and end- users are the factors on which the oral drug delivery market research is based.